Aldredge joins Expression Analysis

Wednesday, September 21, 2011 10:57 AM

Expression Analysis, a provider of genetic and genomic testing and analysis for the pharmaceutical and biotechnology industries, has named Tyler Aldredge vice president of laboratory operations.

Most recently, Aldredge was director of laboratory operations at Genzyme Genetics. He brings genomics experience in both clinical and research laboratories to Expression Analysis.

“Tyler possesses the necessary skill set to lead EA as it continues to grow and expand its service offerings; he will add tremendous benefit to our clients and have a positive impact on our operations, culture and future growth strategies,” said Steve McPhail, CEO and president of EA.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs